Active Ingredient History

NOW
  • Now
Sibutramine, formerly sold under the brand name Meridia among others, is an appetite suppressant which has been discontinued in many countries. Until 2010, it was widely marketed and prescribed as an adjunct in the treatment of obesity along with diet and exercise. It has been associated with increased cardiovascular events and strokes and has been withdrawn from the market in several countries and regions including Australia, Canada, China, the European Union, Hong Kong, India, Mexico, New Zealand, the Philippines, Thailand, the United Kingdom, and the United States. However, the drug remains available in some countries.   Wikipedia

More Chemistry
bts 54524 | bts 54 524 | bts-54524 | butramin | didemethyl sibutramine hcl | didemethyl sibutramine hydrochloride | didesmethylsibutramine | di-desmethylsibutramine | meredia | meridia | mono-desmethylsibutramine | n-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl-n,n-dimethylamine hcl | racemic sibutramine | (r)-ddms | reductil | sibutramina | sibutramine | (+/-)-sibutramine | sibutramine hcl | sibutramine hydrochloride | sibutramine hydrochloride hydrate | sibutramine hydrochloride monohydrate | sibutraminum

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue